The Myeloma Institute for Research and Therapy at the University of Arkansas for Medical Sciences (UAMS) celebrates its 20th anniversary.
As the institute celebrates 20 years of progress, founder and director, Bart Barlogie, M.D., Ph.D., talks in terms of successful treatment for many patients. Based on years of research by Myeloma Institute scientists, clinical trials under way target high-risk and low-risk disease as defined by genetic profiling.
Link to this comment:
All Comments (0)